| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.05M | 32.83M | 35.70M | 31.65M | 21.66M | 14.49M |
| Gross Profit | 23.26M | 21.34M | 20.90M | 16.95M | 7.81M | 3.98M |
| EBITDA | 1.86M | 3.18M | 2.33M | 2.14M | 838.00K | -822.00K |
| Net Income | 1.19M | 2.26M | 3.39M | 2.08M | 458.00K | -2.03M |
Balance Sheet | ||||||
| Total Assets | 38.63M | 32.70M | 30.50M | 20.60M | 19.61M | 6.08M |
| Cash, Cash Equivalents and Short-Term Investments | 4.16M | 7.60M | 6.92M | 6.49M | 5.91M | 2.75M |
| Total Debt | 1.89M | 1.85M | 1.85M | 701.00K | 1.44M | 466.00K |
| Total Liabilities | 14.90M | 11.41M | 11.90M | 10.58M | 12.08M | 5.33M |
| Stockholders Equity | 23.72M | 21.29M | 18.59M | 10.02M | 7.53M | 760.00K |
Cash Flow | ||||||
| Free Cash Flow | -398.00K | 1.46M | 1.67M | 1.63M | 3.96M | -990.00K |
| Operating Cash Flow | -234.00K | 1.62M | 1.82M | 1.71M | 3.99M | -824.00K |
| Investing Cash Flow | -2.06M | -565.00K | -4.74M | -335.00K | -6.32M | -162.00K |
| Financing Cash Flow | -447.00K | -366.00K | 3.35M | -823.00K | 5.49M | -511.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £80.44M | 42.66 | 5.43% | 0.60% | 1.92% | -75.53% | |
68 Neutral | £955.42M | 23.26 | 14.24% | 1.69% | 9.56% | 29.82% | |
65 Neutral | £103.23M | 34.50 | 89.29% | ― | 7.54% | ― | |
65 Neutral | £5.19M | -20.95 | -3.35% | ― | 20.71% | 96.18% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
47 Neutral | £117.78M | -8.64 | ― | 2.10% | -6.63% | -177.14% |
Brave Bison reported that trading for the year ended 31 December 2025 was ahead of market expectations, with unaudited net revenue of at least £33.5m, up 57% year-on-year, and adjusted EBITDA and adjusted profit before tax rising 44% and 41% respectively to no less than £6.5m and £5.5m. Year-end net cash of £4.3m also came in significantly better than consensus, supported by a strong fourth quarter in its Sport & Entertainment activities and an improved working capital position, although some of this benefit is expected to unwind in the first half of 2026. The board now anticipates repaying all outstanding bank debt before the end of 2026, earlier than previously expected, and intends to use surplus free cash flow for further acquisitions and dividends in line with its capital allocation policy, while signalling comfort with FY26 market forecasts and highlighting that revenues and profits will increasingly be second-half weighted due to the scheduling of MiniMBA courses.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £78.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison Group plc, the next-generation marketing and technology partner for global brands, has updated the timing for the admission of 202,451 new ordinary shares arising from the exercise of share options by certain Group employees. The admission of these shares, which form part of the company’s existing employee incentive arrangements, will now occur on 23 December 2025, with all other terms of the issuance remaining unchanged, indicating only a minor administrative adjustment rather than a change in the company’s broader capital or strategic position.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £78.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison announced the exercise of option rights by certain employees, resulting in the issuance of 202,451 new ordinary shares. These shares will be admitted to trading on AIM, increasing the total number of shares in issue to 102,474,298. This move reflects the company’s ongoing growth and commitment to expanding its market influence.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £78.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison has submitted a non-binding proposal to acquire M+C Saatchi Performance for £50 million, aiming to merge it with its existing operations to create a major independent performance marketing company outside the US. The acquisition is expected to significantly boost Brave Bison’s financial performance, potentially increasing its adjusted EBITDA by over 80% and enhancing its market position in the UK and APAC regions. The acquisition will be funded through a new bank facility and a share placement, although there is no certainty of completion.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £71.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.
Brave Bison has appointed Singer Capital Markets as a Joint Broker, working alongside Cavendish Capital Markets, to enhance its market presence and operational capabilities. This strategic move is expected to strengthen the company’s position in the marketing and technology industry, potentially benefiting stakeholders by expanding its reach and services.
The most recent analyst rating on (GB:BBSN) stock is a Hold with a £71.00 price target. To see the full list of analyst forecasts on Brave Bison stock, see the GB:BBSN Stock Forecast page.